Literature DB >> 14581414

Reduction of infarct size and prevention of cardiac rupture in transgenic mice overexpressing FrzA.

Laurent Barandon1, Thierry Couffinhal, Jérome Ezan, Pascale Dufourcq, Pierre Costet, Philippe Alzieu, Lionel Leroux, Catherine Moreau, Danièle Dare, Cécile Duplàa.   

Abstract

BACKGROUND: FrzA/sFRP-1, a secreted, frizzled-related protein and antagonist for the wnt/frizzled pathway, is expressed in the heart and vessels during mouse embryogenesis and adulthood. FrzA is involved in cell cycle control of vascular cells and angiogenesis. We assessed the hypothesis that FrzA could control the healing process after myocardial infarction (MI). METHODS AND
RESULTS: We demonstrated an upregulation of sFRP-1 and distinct wnt and fz member expression after MI. We established transgenic (Tg) mice that overexpress FrzA under a cytomegalovirus promoter and developed a model of MI by coronary artery ligation. FrzA reduced cardiac rupture after MI in Tg (6.5% versus 26.4% in controls; n=165, P<0.01). MI was smaller in Tg at each time point (18+/-10.8% of left ventricular circumference versus 30+/-14.2% in controls at day 30; P<0.001). Similar results were found in cryolesion-induced MI. Cardiac function was improved in Tg mice (3800+/-370 mm Hg/s dP/dtmax versus 2800+/-840 in controls; -2800+/-440 dP/dtmin versus -1800+/-211 in controls at day 15; P<0.001). Early leukocyte infiltration had decreased in Tg mice during the first week. Apoptotic index was decreased by 50% in Tg mice at day 7. Matrix metalloproteinase-2 and -9 activity was reduced in Tg mice at day 4, and collagen deposition in the scar was increased in Tg mice. Capillary density in the scar was higher in Tg mice (290+/-103 vessels/mm2 versus 104+/-43 in controls at day 15; P<0.001). Vessels were more muscularized, and mean lumen area was 3-fold higher in Tg animals.
CONCLUSIONS: Overexpression of FrzA, through direct or indirect interaction with different phases of infarct healing, reduced infarct size and improved cardiac function.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14581414     DOI: 10.1161/01.CIR.0000093186.22847.4C

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  95 in total

1.  Thymosin beta4: a key factor for protective effects of eEPCs in acute and chronic ischemia.

Authors:  Rabea Hinkel; Ildiko Bock-Marquette; Antonis K Hatzopoulos; Antonis K Hazopoulos; Christian Kupatt
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

Review 2.  Winding through the WNT pathway during cellular development and demise.

Authors:  F Li; Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2006-01       Impact factor: 2.303

3.  Chibby, an antagonist of the Wnt/beta-catenin pathway, facilitates cardiomyocyte differentiation of murine embryonic stem cells.

Authors:  Amar M Singh; Feng-Qian Li; Takashi Hamazaki; Hideko Kasahara; Ken-ichi Takemaru; Naohiro Terada
Journal:  Circulation       Date:  2007-01-29       Impact factor: 29.690

4.  Loss of secreted frizzled-related protein-1 leads to deterioration of cardiac function in mice and plays a role in human cardiomyopathy.

Authors:  Piotr Sklepkiewicz; Takayuki Shiomi; Rajbir Kaur; Jie Sun; Susan Kwon; Becky Mercer; Peter Bodine; Ralph Theo Schermuly; Isaac George; P Christian Schulze; Jeanine M D'Armiento
Journal:  Circ Heart Fail       Date:  2015-02-10       Impact factor: 8.790

5.  Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair.

Authors:  Maria Mirotsou; Zhongyan Zhang; Arjun Deb; Lunan Zhang; Massimiliano Gnecchi; Nicolas Noiseux; Hui Mu; Alok Pachori; Victor Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 6.  The Wnt signaling pathway: aging gracefully as a protectionist?

Authors:  Kenneth Maiese; Faqi Li; Zhao Zhong Chong; Yan Chen Shang
Journal:  Pharmacol Ther       Date:  2008-02-11       Impact factor: 12.310

7.  Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct.

Authors:  Dikshya Bastakoty; Sarika Saraswati; Piyush Joshi; James Atkinson; Igor Feoktistov; Jun Liu; Jennifer L Harris; Pampee P Young
Journal:  Cell Stem Cells Regen Med       Date:  2016-05-30

Review 8.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

9.  Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation.

Authors:  Laura C Zelarayán; Claudia Noack; Belaid Sekkali; Jana Kmecova; Christina Gehrke; Anke Renger; Maria-Patapia Zafiriou; Roel van der Nagel; Rainer Dietz; Leon J de Windt; Jean-Luc Balligand; Martin W Bergmann
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

Review 10.  Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation.

Authors:  Jeffrey W Holmes; Zachary Laksman; Lior Gepstein
Journal:  Prog Biophys Mol Biol       Date:  2015-11-23       Impact factor: 3.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.